Literature DB >> 18309139

Trends in perinatal HIV prevention in New York City, 1994-2003.

Vicki B Peters1, Kai-Lih Liu, Lisa-Gaye Robinson, Kenneth L Dominguez, Elaine J Abrams, Balwant S Gill, Pauline A Thomas.   

Abstract

OBJECTIVES: We examined trends in perinatal HIV prevention interventions in New York City implemented during 1994 to 2003 to ascertain the success of the interventions in reducing perinatal transmission.
METHODS: We used data obtained from infant records at 22 hospitals. We used multiple logistic regression to analyze factors associated with prenatal care and perinatal HIV transmission.
RESULTS: We analyzed data for 4729 perinatally HIV-exposed singleton births. Of mothers with prenatal care data, 92% had prenatal care. The overall proportion who received prenatal care and were diagnosed with HIV before delivery was 86% in 1994 to 1996 and 90% in 1997 to 2003. Use of prenatal antiretrovirals among mothers who received prenatal care was 63% in 1994 to 1996 and 82% in 1997 to 2003. From 1994 to 2003, cesarean births among the entire sample increased from 15% to 55%. During 1997 to 2003, the perinatal HIV transmission rate among the entire sample was 7%; 45% of mothers of infected infants had missed opportunities for perinatal HIV prevention. During 1997 to 2003, maternal illicit drug use was significantly associated with lack of prenatal care. Lack of prenatal, intrapartum, and neonatal antiretrovirals; maternal illicit drug use; and low birthweight were significantly associated with perinatal HIV transmission.
CONCLUSIONS: Interventions for perinatal HIV prevention can successfully decrease HIV transmission rates. Ongoing perinatal HIV surveillance allows for monitoring the implementation of guidelines to prevent mother-to-child transmission of HIV and determining factors that may contribute to perinatal HIV transmission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18309139      PMCID: PMC2636456          DOI: 10.2105/AJPH.2007.110023

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  31 in total

1.  HIV infection in heterosexual female intravenous drug users in New York City, 1977-1980.

Authors:  P Thomas; R O'Donnell; R Williams; M A Chiasson
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

2.  Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Authors:  Ellen R Cooper; Manhattan Charurat; Lynne Mofenson; I Celine Hanson; Jane Pitt; Clemente Diaz; Karen Hayani; Edward Handelsman; Vincent Smeriglio; Rodney Hoff; William Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

3.  Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

4.  Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. American Academy of Pediatrics Committee on Pediatric AIDS.

Authors:  Jennifer S Read
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

5.  Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-04-18       Impact factor: 17.586

6.  Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.

Authors:  Marc Lallemant; Gonzague Jourdain; Sophie Le Coeur; Jean Yves Mary; Nicole Ngo-Giang-Huong; Suporn Koetsawang; Siripon Kanshana; Kenneth McIntosh; Vallop Thaineua
Journal:  N Engl J Med       Date:  2004-07-09       Impact factor: 91.245

7.  Decline in perinatal HIV transmission in New York State (1997-2000).

Authors:  Nancy A Wade; Mary A Zielinski; Maia Butsashvili; Louise-Anne McNutt; Barbara L Warren; Roberta Glaros; Babu Cheku; Wendy Pulver; Kenneth Pass; Kathleen Fox; Antonia C Novello; Guthrie S Birkhead
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-15       Impact factor: 3.731

8.  "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Holly Hagan; Judith Milliken; Naomi Braine; Stanley Yancovitz; Donna Mildvan; David C Perlman; Carey Maslow; Samuel R Friedman
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

9.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

10.  Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1994-08-05
View more
  2 in total

Review 1.  The HIV Epidemic: High-Income Countries.

Authors:  Sten H Vermund; Andrew J Leigh-Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

2.  The changing face of HIV in pregnancy in Rhode Island 2004-2009.

Authors:  Jacqueline Firth; Chia-Ching Wang; Fizza Gillani; Nicole Alexander; Elizabeth Dufort; Aadia Rana; Susan Cu-Uvin
Journal:  Infect Dis Obstet Gynecol       Date:  2012-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.